|
G
|
Abca1
|
ATP binding cassette subfamily A member 1
|
multiple interactions
|
ISO
|
[Vancomycin co-treated with Neomycin co-treated with Ampicillin co-treated with Metronidazole co-treated with Amphotericin B] results in decreased expression of ABCA1 mRNA
|
CTD |
PMID:36464106 |
|
NCBI chr 5:72,473,676...72,596,563
Ensembl chr 5:72,473,676...72,596,473
|
|
G
|
Abcb11
|
ATP binding cassette subfamily B member 11
|
multiple interactions
|
ISO
|
[Cephalothin co-treated with Neomycin] results in increased expression of ABCB11 mRNA; [Vancomycin co-treated with Neomycin co-treated with Ampicillin co-treated with Metronidazole co-treated with Amphotericin B] results in increased expression of ABCB11 mRNA
|
CTD |
PMID:24657338 PMID:36464106 |
|
NCBI chr 3:74,424,620...74,520,646
Ensembl chr 3:74,424,979...74,520,581
|
|
G
|
Abcb1a
|
ATP binding cassette subfamily B member 1A
|
multiple interactions
|
ISO
|
[Vancomycin co-treated with Neomycin co-treated with Ampicillin co-treated with Metronidazole co-treated with Amphotericin B] results in increased expression of ABCB1A mRNA
|
CTD |
PMID:36464106 |
|
NCBI chr 4:26,312,403...26,488,456
Ensembl chr 4:26,312,409...26,397,135
|
|
G
|
Abcc2
|
ATP binding cassette subfamily C member 2
|
multiple interactions
|
ISO
|
[Cephalothin co-treated with Neomycin] results in increased expression of ABCC2 mRNA; [Sodium Selenite results in increased abundance of Selenium] inhibits the reaction [[Vancomycin co-treated with Neomycin co-treated with Ampicillin co-treated with Metronidazole co-treated with Amphotericin B] results in increased expression of ABCC2 mRNA]; [Vancomycin co-treated with Neomycin co-treated with Ampicillin co-treated with Metronidazole co-treated with Amphotericin B] results in increased expression of ABCC2 mRNA
|
CTD |
PMID:24657338 PMID:36464106 |
|
NCBI chr 1:252,613,875...252,672,459
Ensembl chr 1:252,614,017...252,673,471
|
|
G
|
Abcc3
|
ATP binding cassette subfamily C member 3
|
multiple interactions
|
ISO
|
[Cephalothin co-treated with Neomycin] results in increased expression of ABCC3 mRNA; [Vancomycin co-treated with Neomycin co-treated with Ampicillin co-treated with Metronidazole co-treated with Amphotericin B] results in increased expression of ABCC3 mRNA
|
CTD |
PMID:24657338 PMID:36464106 |
|
NCBI chr10:79,793,571...79,839,528
Ensembl chr10:79,793,583...79,839,494
|
|
G
|
Abcg2
|
ATP binding cassette subfamily G member 2
|
multiple interactions
|
ISO
|
[Sodium Selenite results in increased abundance of Selenium] inhibits the reaction [[Vancomycin co-treated with Neomycin co-treated with Ampicillin co-treated with Metronidazole co-treated with Amphotericin B] results in increased expression of ABCG2 mRNA]; [Vancomycin co-treated with Neomycin co-treated with Ampicillin co-treated with Metronidazole co-treated with Amphotericin B] results in increased expression of ABCG2 mRNA
|
CTD |
PMID:36464106 |
|
NCBI chr 4:89,006,056...89,132,915
Ensembl chr 4:89,005,969...89,132,493
|
|
G
|
Abcg5
|
ATP binding cassette subfamily G member 5
|
multiple interactions
|
ISO
|
[Sodium Selenite results in increased abundance of Selenium] inhibits the reaction [[Vancomycin co-treated with Neomycin co-treated with Ampicillin co-treated with Metronidazole co-treated with Amphotericin B] results in decreased expression of ABCG5 mRNA]; [Vancomycin co-treated with Neomycin co-treated with Ampicillin co-treated with Metronidazole co-treated with Amphotericin B] results in decreased expression of ABCG5 mRNA
|
CTD |
PMID:36464106 |
|
NCBI chr 6:15,717,936...15,743,376
Ensembl chr 6:15,717,936...15,743,376
|
|
G
|
Acaca
|
acetyl-CoA carboxylase alpha
|
multiple interactions
|
ISO
|
[Vancomycin co-treated with Metronidazole co-treated with Ampicillin co-treated with Neomycin] inhibits the reaction [bisphenol A results in decreased expression of ACACA protein]; [Vancomycin co-treated with Neomycin co-treated with Metronidazole co-treated with elemicin] results in increased expression of ACACA mRNA
|
CTD |
PMID:34979169 PMID:37211107 |
|
NCBI chr10:69,511,627...69,773,888
Ensembl chr10:69,511,857...69,773,888
|
|
G
|
Acacb
|
acetyl-CoA carboxylase beta
|
multiple interactions
|
ISO
|
[Vancomycin co-treated with Metronidazole co-treated with Ampicillin co-treated with Neomycin] inhibits the reaction [bisphenol A results in decreased expression of ACACB protein]
|
CTD |
PMID:37211107 |
|
NCBI chr12:48,026,394...48,138,214
Ensembl chr12:48,026,394...48,138,214
|
|
G
|
Acat2
|
acetyl-CoA acetyltransferase 2
|
multiple interactions
|
EXP
|
[Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in increased expression of ACAT2 protein
|
CTD |
PMID:30545405 |
|
NCBI chr 1:50,100,840...50,118,886
Ensembl chr 1:50,100,817...50,135,095
|
|
G
|
Acat2l1
|
acetyl-CoA acetyltransferase 2-like 1
|
multiple interactions
|
EXP
|
[Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in increased expression of ACAT2L1 protein
|
CTD |
PMID:30545405 |
|
NCBI chr 1:50,341,596...50,376,961
Ensembl chr 1:50,359,869...50,376,959
|
|
G
|
Ace2
|
angiotensin converting enzyme 2
|
multiple interactions
|
EXP
|
[Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in increased expression of ACE2 protein
|
CTD |
PMID:30545405 |
|
NCBI chr X:33,925,458...33,972,851
Ensembl chr X:33,925,458...33,971,596
|
|
G
|
Ada
|
adenosine deaminase
|
decreases activity multiple interactions
|
ISO
|
Neomycin results in decreased activity of ADA protein Tetrachlorodibenzodioxin inhibits the reaction [Neomycin results in decreased activity of ADA protein]
|
CTD |
PMID:7853360 |
|
NCBI chr 3:172,818,174...172,842,283
Ensembl chr 3:172,818,176...172,842,293
|
|
G
|
Adipoq
|
adiponectin, C1Q and collagen domain containing
|
multiple interactions
|
ISO
|
[Vancomycin co-treated with Neomycin co-treated with Metronidazole co-treated with elemicin] results in increased expression of ADIPOQ mRNA
|
CTD |
PMID:34979169 |
|
NCBI chr11:91,226,524...91,240,244
Ensembl chr11:91,226,180...91,240,169
|
|
G
|
Ahsg
|
alpha-2-HS-glycoprotein
|
multiple interactions
|
EXP
|
[Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in increased expression of AHSG protein
|
CTD |
PMID:30545405 |
|
NCBI chr11:91,625,975...91,632,583
Ensembl chr11:91,625,975...91,634,039
|
|
G
|
Aldoa
|
aldolase, fructose-bisphosphate A
|
multiple interactions
|
EXP
|
[Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in increased expression of ALDOA protein
|
CTD |
PMID:30545405 |
|
NCBI chr 1:190,832,820...190,838,021
Ensembl chr 1:190,832,820...190,838,211
|
|
G
|
Aldob
|
aldolase, fructose-bisphosphate B
|
multiple interactions
|
EXP
|
[Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in increased expression of ALDOB protein
|
CTD |
PMID:30545405 |
|
NCBI chr 5:68,684,541...68,697,582
Ensembl chr 5:68,684,542...68,716,740
|
|
G
|
Amy2a3
|
amylase 2a3
|
multiple interactions
|
EXP
|
[Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in decreased expression of AMY2A3 protein
|
CTD |
PMID:30545405 |
|
NCBI chr 2:204,005,840...204,014,412
Ensembl chr 2:204,005,840...204,014,413
|
|
G
|
Apaf1
|
apoptotic peptidase activating factor 1
|
increases expression multiple interactions
|
ISO
|
Neomycin results in increased expression of APAF1 mRNA peoniflorin inhibits the reaction [Neomycin results in increased expression of APAF1 mRNA]
|
CTD |
PMID:29292089 |
|
NCBI chr 7:27,381,392...27,466,772
Ensembl chr 7:27,381,855...27,466,772
|
|
G
|
Arg2
|
arginase 2
|
multiple interactions
|
EXP
|
[Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in decreased expression of ARG2 protein
|
CTD |
PMID:30545405 |
|
NCBI chr 6:103,669,001...103,694,375
Ensembl chr 6:103,668,988...103,694,375
|
|
G
|
Arpc3
|
actin related protein 2/3 complex, subunit 3
|
multiple interactions
|
EXP
|
[Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in increased expression of ARPC3 protein
|
CTD |
PMID:30545405 |
|
NCBI chr12:39,833,569...39,847,436
Ensembl chr12:39,833,569...39,847,436
|
|
G
|
Asah1
|
N-acylsphingosine amidohydrolase 1
|
multiple interactions
|
EXP
|
[Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in decreased expression of ASAH1 protein
|
CTD |
PMID:30545405 |
|
NCBI chr16:57,669,927...57,701,349
Ensembl chr16:57,669,750...57,718,305
|
|
G
|
Atp1a1
|
ATPase Na+/K+ transporting subunit alpha 1
|
multiple interactions
|
EXP
|
[Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in increased expression of ATP1A1 protein
|
CTD |
PMID:30545405 |
|
NCBI chr 2:191,709,311...191,737,414
Ensembl chr 2:191,709,311...191,737,425
|
|
G
|
Atp2a3
|
ATPase sarcoplasmic/endoplasmic reticulum Ca2+ transporting 3
|
multiple interactions
|
EXP
|
[Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in increased expression of ATP2A3 protein
|
CTD |
PMID:30545405 |
|
NCBI chr10:58,079,710...58,111,279
Ensembl chr10:58,079,852...58,111,278
|
|
G
|
Atp5mf
|
ATP synthase membrane subunit f
|
multiple interactions
|
EXP
|
[Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in increased expression of ATP5MF protein
|
CTD |
PMID:30545405 |
|
NCBI chr12:14,535,435...14,542,007
Ensembl chr12:14,522,832...14,542,709
|
|
G
|
Atp5pd
|
ATP synthase peripheral stalk subunit d
|
multiple interactions
|
EXP
|
[Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in increased expression of ATP5PD protein
|
CTD |
PMID:30545405 |
|
NCBI chr10:101,156,673...101,161,926
Ensembl chr10:101,156,673...101,162,954
|
|
G
|
Atp5pf
|
ATP synthase peripheral stalk subunit F6
|
multiple interactions
|
EXP
|
[Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in increased expression of ATP5PF protein
|
CTD |
PMID:30545405 |
|
NCBI chr11:37,368,045...37,375,721
Ensembl chr11:37,368,042...37,375,466
|
|
G
|
B3galt5
|
Beta-1,3-galactosyltransferase 5
|
multiple interactions
|
EXP
|
[Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in increased expression of B3GALT5 protein
|
CTD |
PMID:30545405 |
|
NCBI chr11:49,053,959...49,100,398
Ensembl chr11:49,006,560...49,101,283
|
|
G
|
Bax
|
BCL2 associated X, apoptosis regulator
|
multiple interactions increases expression
|
ISO
|
peoniflorin inhibits the reaction [Neomycin results in increased expression of BAX mRNA]
|
CTD |
PMID:29292089 |
|
NCBI chr 1:105,076,472...105,081,906
Ensembl chr 1:105,076,473...105,086,429
|
|
G
|
Bcat1
|
branched chain amino acid transaminase 1
|
decreases expression
|
ISO
|
Neomycin results in decreased expression of BCAT1 mRNA
|
CTD |
PMID:30626089 |
|
NCBI chr 4:179,695,662...179,777,973
Ensembl chr 4:179,695,662...179,777,288
|
|
G
|
Bcl2
|
BCL2, apoptosis regulator
|
multiple interactions decreases expression
|
ISO
|
peoniflorin inhibits the reaction [Neomycin results in decreased expression of BCL2 mRNA]; peoniflorin inhibits the reaction [Neomycin results in decreased expression of BCL2 protein] Neomycin results in decreased expression of BCL2 mRNA; Neomycin results in decreased expression of BCL2 protein
|
CTD |
PMID:29292089 |
|
NCBI chr13:23,204,464...23,366,900
Ensembl chr13:23,204,464...23,366,900
|
|
G
|
Casp3
|
caspase 3
|
multiple interactions affects cleavage increases expression increases cleavage
|
ISO
|
BIX 01294 affects the reaction [Neomycin affects the cleavage of CASP3 protein]; NOL3 protein affects the reaction [Neomycin results in increased cleavage of CASP3 protein]; peoniflorin inhibits the reaction [Neomycin results in increased expression of CASP3 mRNA]; peoniflorin inhibits the reaction [Neomycin results in increased expression of CASP3 protein modified form] Neomycin results in increased expression of CASP3 mRNA; Neomycin results in increased expression of CASP3 protein modified form
|
CTD |
PMID:23429292 PMID:29292089 PMID:39667535 |
|
NCBI chr16:52,395,539...52,413,794
Ensembl chr16:52,395,540...52,413,732
|
|
G
|
Casp9
|
caspase 9
|
increases expression multiple interactions
|
ISO
|
Neomycin results in increased expression of CASP9 mRNA; Neomycin results in increased expression of CASP9 protein modified form peoniflorin inhibits the reaction [Neomycin results in increased expression of CASP9 mRNA]; peoniflorin inhibits the reaction [Neomycin results in increased expression of CASP9 protein modified form]
|
CTD |
PMID:29292089 |
|
Ensembl chr 5:159,391,188...159,409,648
|
|
G
|
Casr
|
calcium-sensing receptor
|
multiple interactions
|
ISO EXP
|
CASR protein promotes the reaction [Neomycin results in increased phosphorylation of and results in increased activity of MAPK1 protein]; CASR protein promotes the reaction [Neomycin results in increased phosphorylation of and results in increased activity of MAPK3 protein]; Neomycin binds to and results in increased activity of CASR protein [Neomycin binds to and results in increased activity of CASR protein] which results in increased abundance of Calcium; [Neomycin binds to and results in increased activity of CASR protein] which results in increased abundance of Inositol Phosphates; Neomycin binds to and results in increased activity of CASR protein
|
CTD |
PMID:10231437 PMID:17537980 |
|
NCBI chr11:77,738,398...77,813,639
Ensembl chr11:77,740,614...77,810,167
|
|
G
|
Ccng2
|
cyclin G2
|
increases expression
|
ISO
|
Neomycin results in increased expression of CCNG2 mRNA
|
CTD |
PMID:30626089 |
|
NCBI chr14:15,088,694...15,097,190
Ensembl chr14:15,088,695...15,096,206
|
|
G
|
Cd86
|
CD86 molecule
|
increases expression
|
ISO
|
Neomycin results in increased expression of CD86 protein
|
CTD |
PMID:19665512 |
|
NCBI chr11:77,647,565...77,706,178
Ensembl chr11:77,647,600...77,725,361
|
|
G
|
Cdh1
|
cadherin 1
|
decreases expression
|
ISO
|
Neomycin results in decreased expression of CDH1 protein
|
CTD |
PMID:15953529 |
|
NCBI chr19:51,402,178...51,471,572
Ensembl chr19:51,402,034...51,471,565
|
|
G
|
Clca4
|
chloride channel accessory 4
|
multiple interactions
|
EXP
|
[Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in increased expression of CLCA4 protein
|
CTD |
PMID:30545405 |
|
NCBI chr 2:236,543,975...236,565,096
Ensembl chr 2:236,544,201...236,563,435
|
|
G
|
Cldn5
|
claudin 5
|
multiple interactions
|
ISO
|
[Neomycin co-treated with Metronidazole co-treated with Ampicillin co-treated with Vancomycin] inhibits the reaction [Methamphetamine results in decreased expression of CLDN5 mRNA]; [Neomycin co-treated with Metronidazole co-treated with Ampicillin co-treated with Vancomycin] inhibits the reaction [Methamphetamine results in decreased expression of CLDN5 protein]
|
CTD |
PMID:35390362 |
|
NCBI chr11:95,717,172...95,718,598
Ensembl chr11:95,717,176...95,719,322
|
|
G
|
Cldn7
|
claudin 7
|
multiple interactions
|
EXP
|
[Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in increased expression of CLDN7 protein
|
CTD |
PMID:30545405 |
|
NCBI chr10:55,188,670...55,190,871
Ensembl chr10:55,188,684...55,190,905
|
|
G
|
Cmbl
|
carboxymethylenebutenolidase homolog
|
multiple interactions
|
EXP
|
[Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in decreased expression of CMBL protein
|
CTD |
PMID:30545405 |
|
NCBI chr 2:84,280,128...84,301,878
Ensembl chr 2:84,242,512...84,301,880
|
|
G
|
Cndp2
|
carnosine dipeptidase 2
|
multiple interactions
|
EXP
|
[Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in increased expression of CNDP2 protein
|
CTD |
PMID:30545405 |
|
NCBI chr18:80,314,799...80,331,900
Ensembl chr18:80,314,801...80,331,900
|
|
G
|
Cox5a
|
cytochrome c oxidase subunit 5A
|
multiple interactions
|
EXP
|
[Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in increased expression of COX5A protein
|
CTD |
PMID:30545405 |
|
NCBI chr 8:66,818,284...66,829,691
Ensembl chr 8:66,818,196...66,830,279
|
|
G
|
Cox6b1
|
cytochrome c oxidase subunit 6B1
|
multiple interactions
|
EXP
|
[Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in increased expression of COX6B1 protein
|
CTD |
PMID:30545405 |
|
NCBI chr 1:95,002,513...95,011,516
Ensembl chr 1:95,001,707...95,011,431 Ensembl chr 5:95,001,707...95,011,431
|
|
G
|
Cox6c
|
cytochrome c oxidase subunit 6C
|
multiple interactions
|
EXP
|
[Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in increased expression of COX6C2 protein
|
CTD |
PMID:30545405 |
|
NCBI chr 7:69,014,410...69,027,145
Ensembl chr 7:69,014,417...69,027,166
|
|
G
|
Cox7a2
|
cytochrome c oxidase subunit 7A2
|
multiple interactions
|
EXP
|
[Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in increased expression of COX7A2 protein
|
CTD |
PMID:30545405 |
|
NCBI chr 8:89,597,051...89,611,032
Ensembl chr14:55,514,261...55,514,512 Ensembl chr 8:55,514,261...55,514,512
|
|
G
|
Creb1
|
cAMP responsive element binding protein 1
|
multiple interactions increases phosphorylation
|
ISO
|
NOL3 protein affects the reaction [Neomycin results in increased phosphorylation of CREB1 protein]
|
CTD |
PMID:39667535 |
|
NCBI chr 9:73,397,333...73,466,339
Ensembl chr 9:73,397,306...73,466,339
|
|
G
|
Csf2
|
colony stimulating factor 2
|
multiple interactions
|
ISO
|
[Ampicillin co-treated with Vancomycin co-treated with Neomycin co-treated with Metronidazole] inhibits the reaction [Dextran Sulfate results in increased expression of CSF2 protein]; [Ampicillin co-treated with Vancomycin co-treated with Neomycin co-treated with Metronidazole] results in decreased expression of CSF2 protein
|
CTD |
PMID:31442584 |
|
NCBI chr10:38,887,692...38,889,673
Ensembl chr10:38,887,692...38,890,031
|
|
G
|
Cth
|
cystathionine gamma-lyase
|
multiple interactions decreases expression
|
ISO
|
Plant Oils inhibits the reaction [Neomycin results in decreased expression of CTH mRNA]
|
CTD |
PMID:30626089 |
|
NCBI chr 2:249,634,731...249,661,066
Ensembl chr 2:249,634,731...249,661,066
|
|
G
|
Ctsa
|
cathepsin A
|
multiple interactions
|
EXP
|
[Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in decreased expression of CTSA protein
|
CTD |
PMID:30545405 |
|
NCBI chr 3:173,988,443...173,994,320
Ensembl chr 3:173,988,460...173,995,539
|
|
G
|
Cxcl9
|
C-X-C motif chemokine ligand 9
|
multiple interactions
|
ISO
|
[Vancomycin co-treated with Neomycin co-treated with Cilastatin, Imipenem Drug Combination] inhibits the reaction [Doxorubicin results in increased expression of CXCL9 mRNA]; [Vancomycin co-treated with Neomycin co-treated with Cilastatin, Imipenem Drug Combination] inhibits the reaction [Nanotubes, Carbon promotes the reaction [Doxorubicin results in increased expression of CXCL9 mRNA]]
|
CTD |
PMID:32068018 |
|
NCBI chr14:16,007,166...16,012,077
Ensembl chr14:16,007,204...16,014,299
|
|
G
|
Cyp1a2
|
cytochrome P450, family 1, subfamily a, polypeptide 2
|
multiple interactions
|
EXP
|
[Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in decreased expression of CYP1A2 mRNA
|
CTD |
PMID:30545405 |
|
NCBI chr 8:66,971,261...66,978,149
Ensembl chr 8:66,971,261...66,978,149
|
|
G
|
Cyp27a1
|
cytochrome P450, family 27, subfamily a, polypeptide 1
|
multiple interactions
|
ISO
|
[Sodium Selenite results in increased abundance of Selenium] inhibits the reaction [[Vancomycin co-treated with Neomycin co-treated with Ampicillin co-treated with Metronidazole co-treated with Amphotericin B] results in decreased expression of CYP27A1 mRNA]; [Vancomycin co-treated with Neomycin co-treated with Ampicillin co-treated with Metronidazole co-treated with Amphotericin B] results in decreased expression of CYP27A1 mRNA
|
CTD |
PMID:36464106 |
|
NCBI chr 9:83,712,402...83,743,222
Ensembl chr 9:83,713,293...83,743,215
|
|
G
|
Cyp2c11
|
cytochrome P450, subfamily 2, polypeptide 11
|
multiple interactions
|
EXP
|
[Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in decreased expression of CYP2C11 mRNA
|
CTD |
PMID:30545405 |
|
NCBI chr 1:246,175,216...246,211,445
Ensembl chr 1:246,174,711...246,211,853
|
|
G
|
Cyp2d2
|
cytochrome P450, family 2, subfamily d, polypeptide 2
|
multiple interactions
|
EXP
|
[Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in decreased expression of CYP2D2 mRNA
|
CTD |
PMID:30545405 |
|
NCBI chr 7:115,815,212...115,819,281
Ensembl chr 7:115,815,212...115,819,281
|
|
G
|
Cyp2e1
|
cytochrome P450, family 2, subfamily e, polypeptide 1
|
multiple interactions
|
EXP
|
[Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in decreased expression of CYP2E1 mRNA
|
CTD |
PMID:30545405 |
|
NCBI chr 1:205,269,967...205,280,365
Ensembl chr 1:205,267,505...205,293,495
|
|
G
|
Cyp3a2
|
cytochrome P450, family 3, subfamily a, polypeptide 2
|
multiple interactions
|
EXP
|
[Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in decreased expression of CYP3A2 mRNA
|
CTD |
PMID:30545405 |
|
NCBI chr12:14,321,771...14,343,886
Ensembl chr12:14,321,771...14,343,857
|
|
G
|
Cyp7a1
|
cytochrome P450 family 7 subfamily A member 1
|
multiple interactions
|
ISO
|
[Sodium Selenite results in increased abundance of Selenium] inhibits the reaction [[Vancomycin co-treated with Neomycin co-treated with Ampicillin co-treated with Metronidazole co-treated with Amphotericin B] results in decreased expression of CYP7A1 mRNA]; [Vancomycin co-treated with Metronidazole co-treated with Ampicillin co-treated with Neomycin] inhibits the reaction [bisphenol A results in increased expression of CYP7A1 protein]; [Vancomycin co-treated with Neomycin co-treated with Ampicillin co-treated with Metronidazole co-treated with Amphotericin B] results in decreased expression of CYP7A1 mRNA
|
CTD |
PMID:36464106 PMID:37211107 |
|
NCBI chr 5:24,174,505...24,184,202
Ensembl chr 5:24,174,505...24,184,202
|
|
G
|
Cyp7b1
|
cytochrome P450 family 7 subfamily B member 1
|
multiple interactions
|
ISO
|
[Vancomycin co-treated with Neomycin co-treated with Ampicillin co-treated with Metronidazole co-treated with Amphotericin B] results in decreased expression of CYP7B1 mRNA
|
CTD |
PMID:36464106 |
|
NCBI chr 2:102,419,011...102,586,047
Ensembl chr 2:102,419,011...102,451,804
|
|
G
|
Cyp8b1
|
cytochrome P450 family 8 subfamily B member 1
|
multiple interactions
|
ISO
|
[Cephalothin co-treated with Neomycin] results in decreased expression of CYP8B1 mRNA; [Sodium Selenite results in increased abundance of Selenium] inhibits the reaction [[Vancomycin co-treated with Neomycin co-treated with Ampicillin co-treated with Metronidazole co-treated with Amphotericin B] results in decreased expression of CYP8B1 mRNA]; [Vancomycin co-treated with Neomycin co-treated with Ampicillin co-treated with Metronidazole co-treated with Amphotericin B] results in decreased expression of CYP8B1 mRNA
|
CTD |
PMID:24657338 PMID:36464106 |
|
NCBI chr 8:130,455,622...130,457,592
Ensembl chr 8:130,442,503...130,457,689
|
|
G
|
Epcam
|
epithelial cell adhesion molecule
|
multiple interactions
|
EXP
|
[Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in increased expression of EPCAM protein
|
CTD |
PMID:30545405 |
|
NCBI chr 6:12,633,715...12,649,678
Ensembl chr 6:12,631,611...12,649,702
|
|
G
|
Etfa
|
electron transfer flavoprotein subunit alpha
|
multiple interactions
|
EXP
|
[Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in increased expression of ETFA protein
|
CTD |
PMID:30545405 |
|
NCBI chr 8:64,731,192...64,787,965
Ensembl chr 8:64,731,193...64,788,080
|
|
G
|
Ezr
|
ezrin
|
multiple interactions
|
EXP
|
[Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in increased expression of EZR protein
|
CTD |
PMID:30545405 |
|
NCBI chr 1:49,373,033...49,416,573
Ensembl chr 1:49,373,035...49,416,573
|
|
G
|
Fasn
|
fatty acid synthase
|
multiple interactions
|
ISO
|
[Sodium Selenite results in increased abundance of Selenium] inhibits the reaction [[Vancomycin co-treated with Neomycin co-treated with Ampicillin co-treated with Metronidazole co-treated with Amphotericin B] results in increased expression of FASN mRNA]; [Vancomycin co-treated with Neomycin co-treated with Ampicillin co-treated with Metronidazole co-treated with Amphotericin B] results in increased expression of FASN mRNA; [Vancomycin co-treated with Neomycin co-treated with Metronidazole] inhibits the reaction [elemicin results in increased expression of FASN mRNA]
|
CTD |
PMID:34979169 PMID:36464106 |
|
NCBI chr10:106,570,415...106,588,581
Ensembl chr10:106,570,413...106,588,583
|
|
G
|
Fgf19
|
fibroblast growth factor 19
|
multiple interactions
|
ISO
|
[Cephalothin co-treated with Neomycin] results in increased expression of FGF15 mRNA
|
CTD |
PMID:24657338 |
|
NCBI chr 1:209,485,813...209,490,267
Ensembl chr 1:209,485,813...209,490,267
|
|
G
|
Foxo1
|
forkhead box O1
|
multiple interactions increases expression
|
ISO
|
Plant Oils inhibits the reaction [Neomycin results in increased expression of FOXO1 mRNA]
|
CTD |
PMID:30626089 |
|
NCBI chr 2:138,462,974...138,541,420
Ensembl chr 2:138,462,697...138,541,419
|
|
G
|
Gadd45g
|
growth arrest and DNA-damage-inducible, gamma
|
increases expression multiple interactions
|
ISO
|
Neomycin results in increased expression of GADD45G mRNA Plant Oils inhibits the reaction [Neomycin results in increased expression of GADD45G mRNA]
|
CTD |
PMID:30626089 |
|
NCBI chr17:13,528,606...13,530,351
Ensembl chr17:13,528,610...13,530,369
|
|
G
|
Gclm
|
glutamate cysteine ligase, modifier subunit
|
multiple interactions
|
ISO
|
[Vancomycin co-treated with Neomycin co-treated with Metronidazole] promotes the reaction [Zinc Oxide analog results in increased expression of GCLM protein]
|
CTD |
PMID:36535435 |
|
NCBI chr 2:213,032,135...213,052,192
Ensembl chr 2:213,031,838...213,055,003
|
|
G
|
Gfpt2
|
glutamine-fructose-6-phosphate transaminase 2
|
multiple interactions
|
EXP
|
[Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in increased expression of GFPT2 protein
|
CTD |
PMID:30545405 |
|
NCBI chr10:34,616,146...34,662,420
Ensembl chr10:34,615,370...34,662,419
|
|
G
|
Gipc2
|
GIPC PDZ domain containing family, member 2
|
multiple interactions
|
EXP
|
[Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in increased expression of GIPC2 protein
|
CTD |
PMID:30545405 |
|
NCBI chr 2:243,690,742...243,770,199
Ensembl chr 2:243,690,748...243,770,199
|
|
G
|
Gng12
|
G protein subunit gamma 12
|
multiple interactions
|
EXP
|
[Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in increased expression of GNG12 protein
|
CTD |
PMID:30545405 |
|
NCBI chr 4:97,340,830...97,464,422
Ensembl chr 4:97,340,472...97,464,476
|
|
G
|
Gpbar1
|
G protein-coupled bile acid receptor 1
|
multiple interactions
|
ISO
|
[Vancomycin co-treated with Metronidazole co-treated with Ampicillin co-treated with Neomycin] inhibits the reaction [bisphenol A results in decreased expression of GPBAR1 protein]
|
CTD |
PMID:37211107 |
|
NCBI chr 9:83,309,895...83,312,397
Ensembl chr 9:83,311,246...83,315,608
|
|
G
|
Gpt
|
glutamic--pyruvic transaminase
|
multiple interactions
|
ISO
|
[Sodium Selenite results in increased abundance of Selenium] inhibits the reaction [[Vancomycin co-treated with Neomycin co-treated with Ampicillin co-treated with Metronidazole co-treated with Amphotericin B] results in increased activity of GPT protein]; [Vancomycin co-treated with Neomycin co-treated with Ampicillin co-treated with Metronidazole co-treated with Amphotericin B] results in increased activity of GPT protein; [Vancomycin co-treated with Neomycin co-treated with Metronidazole] inhibits the reaction [elemicin results in increased activity of GPT protein]
|
CTD |
PMID:34979169 PMID:36464106 |
|
NCBI chr 7:110,295,599...110,300,134
Ensembl chr 7:110,296,206...110,300,160
|
|
G
|
Gpt2
|
glutamic--pyruvic transaminase 2
|
decreases expression
|
ISO
|
Neomycin results in decreased expression of GPT2 mRNA
|
CTD |
PMID:30626089 |
|
NCBI chr19:37,700,023...37,734,551
Ensembl chr19:37,691,901...37,733,917
|
|
G
|
Gpx1
|
glutathione peroxidase 1
|
multiple interactions
|
EXP
|
[Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in decreased expression of GPX1 protein
|
CTD |
PMID:30545405 |
|
NCBI chr 8:117,905,462...117,906,588
Ensembl chr 8:117,905,280...117,906,581
|
|
G
|
Gsta3
|
glutathione S-transferase alpha 3
|
multiple interactions
|
EXP
|
[Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in decreased expression of GSTA3 mRNA
|
CTD |
PMID:30545405 |
|
NCBI chr 9:31,154,989...31,180,653
Ensembl chr 9:31,154,989...31,180,654
|
|
G
|
Gstm2
|
glutathione S-transferase mu 2
|
multiple interactions
|
EXP
|
[Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in decreased expression of GSTM2 mRNA
|
CTD |
PMID:30545405 |
|
NCBI chr 2:198,312,179...198,316,962
|
|
G
|
Hexb
|
hexosaminidase subunit beta
|
multiple interactions
|
EXP
|
[Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in decreased expression of HEXB protein
|
CTD |
PMID:30545405 |
|
NCBI chr 2:30,218,608...30,238,771
Ensembl chr 2:30,218,608...30,238,771
|
|
G
|
Hmgcr
|
3-hydroxy-3-methylglutaryl-CoA reductase
|
multiple interactions
|
ISO
|
[Sodium Selenite results in increased abundance of Selenium] inhibits the reaction [[Vancomycin co-treated with Neomycin co-treated with Ampicillin co-treated with Metronidazole co-treated with Amphotericin B] results in increased expression of HMGCR mRNA]; [Vancomycin co-treated with Neomycin co-treated with Ampicillin co-treated with Metronidazole co-treated with Amphotericin B] results in increased expression of HMGCR mRNA
|
CTD |
PMID:36464106 |
|
NCBI chr 2:29,732,163...29,754,276
Ensembl chr 2:29,720,553...29,754,533
|
|
G
|
Hmox1
|
heme oxygenase 1
|
multiple interactions
|
ISO
|
[Vancomycin co-treated with Neomycin co-treated with Metronidazole] promotes the reaction [Zinc Oxide analog results in increased expression of HMOX1 protein]
|
CTD |
PMID:36535435 |
|
NCBI chr19:13,452,365...13,479,823
Ensembl chr19:13,472,884...13,479,818
|
|
G
|
Hnrnph2
|
heterogeneous nuclear ribonucleoprotein H2
|
multiple interactions
|
EXP
|
[Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in increased expression of HNRNPH2 protein
|
CTD |
PMID:30545405 |
|
NCBI chr X:102,074,175...102,080,115
Ensembl chr X:102,074,179...102,081,025
|
|
G
|
Hp
|
haptoglobin
|
multiple interactions
|
EXP
|
[Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in increased expression of HP protein
|
CTD |
PMID:30545405 |
|
NCBI chr19:54,449,151...54,453,701
Ensembl chr19:54,446,217...54,467,518
|
|
G
|
Hspd1
|
heat shock protein family D (Hsp60) member 1
|
multiple interactions
|
EXP
|
Neomycin inhibits the reaction [Adenosine Triphosphate results in increased expression of HSPD1 protein]
|
CTD |
PMID:16178011 |
|
NCBI chr 9:64,073,610...64,084,332
Ensembl chr 9:64,073,611...64,084,037
|
|
G
|
Htr4
|
5-hydroxytryptamine receptor 4
|
multiple interactions
|
ISO
|
[Vancomycin co-treated with Neomycin co-treated with Metronidazole] promotes the reaction [Zinc Oxide results in increased expression of HTR4 mRNA]; [Vancomycin co-treated with Neomycin co-treated with Metronidazole] results in increased expression of HTR4 mRNA
|
CTD |
PMID:36535435 |
|
NCBI chr18:58,036,277...58,221,327
Ensembl chr18:58,036,277...58,219,622
|
|
G
|
Il18
|
interleukin 18
|
multiple interactions
|
ISO
|
[Metronidazole co-treated with Ampicillin co-treated with Neomycin] inhibits the reaction [bisphenol S results in increased expression of IL18 protein]; [Neomycin co-treated with Metronidazole co-treated with Ampicillin co-treated with Vancomycin] inhibits the reaction [Methamphetamine results in increased secretion of IL18 protein]
|
CTD |
PMID:35390362 PMID:38908815 |
|
NCBI chr 8:59,802,072...59,829,275
Ensembl chr 8:59,809,592...59,831,286
|
|
G
|
Il1b
|
interleukin 1 beta
|
multiple interactions
|
ISO
|
[Neomycin co-treated with Metronidazole co-treated with Ampicillin co-treated with Vancomycin] inhibits the reaction [Methamphetamine results in increased expression of and results in increased secretion of IL1B protein]; [Neomycin co-treated with Metronidazole co-treated with Ampicillin co-treated with Vancomycin] inhibits the reaction [Methamphetamine results in increased expression of IL1B mRNA]; [Vancomycin co-treated with Neomycin co-treated with Cilastatin, Imipenem Drug Combination] inhibits the reaction [Doxorubicin results in increased expression of IL1B protein]; [Vancomycin co-treated with Neomycin co-treated with Cilastatin, Imipenem Drug Combination] inhibits the reaction [Nanotubes, Carbon promotes the reaction [Doxorubicin results in increased expression of IL1B protein]]
|
CTD |
PMID:32068018 PMID:35390362 |
|
NCBI chr 3:137,030,200...137,036,581
Ensembl chr 3:137,030,205...137,036,601
|
|
G
|
Il6
|
interleukin 6
|
multiple interactions
|
ISO
|
[Ampicillin co-treated with Vancomycin co-treated with Neomycin co-treated with Metronidazole] inhibits the reaction [Dextran Sulfate results in increased expression of IL6 protein]; [Ampicillin co-treated with Vancomycin co-treated with Neomycin co-treated with Metronidazole] results in decreased expression of IL6 protein; Dextran Sulfate inhibits the reaction [[Ampicillin co-treated with Vancomycin co-treated with Neomycin co-treated with Metronidazole] results in decreased expression of IL6 protein]
|
CTD |
PMID:31442584 |
|
NCBI chr 4:5,889,999...5,894,575
Ensembl chr 4:5,889,999...5,894,610
|
|
G
|
Inhba
|
inhibin subunit beta A
|
increases expression
|
ISO
|
Neomycin results in increased expression of INHBA mRNA
|
CTD |
PMID:30626089 |
|
NCBI chr17:53,787,159...53,810,942
Ensembl chr17:53,791,444...53,804,508
|
|
G
|
Ins2
|
insulin 2
|
multiple interactions
|
EXP
|
Neomycin inhibits the reaction [INS protein results in increased uptake of cobaltous chloride]
|
CTD |
PMID:14622148 |
|
NCBI chr 1:207,272,738...207,421,998
Ensembl chr 1:207,272,742...207,273,805
|
|
G
|
Irs2
|
insulin receptor substrate 2
|
increases expression
|
ISO
|
Neomycin results in increased expression of IRS2 mRNA
|
CTD |
PMID:30626089 |
|
NCBI chr16:85,190,310...85,214,543
Ensembl chr16:85,190,111...85,214,543
|
|
G
|
Jun
|
Jun proto-oncogene, AP-1 transcription factor subunit
|
multiple interactions increases expression increases phosphorylation
|
EXP ISO
|
3,9-bis((ethylthio)methyl)-K-252a inhibits the reaction [Neomycin results in increased expression of JUN protein modified form] 4-(9-(tetrahydrofuran-3-yl))-8-(2,4,6-trifluorophenylamino)-9H-purin-2-ylaminocyclohexan-1-ol inhibits the reaction [Neomycin results in increased phosphorylation of JUN protein]; FTI 277 inhibits the reaction [Neomycin results in increased phosphorylation of JUN protein]; NOL3 protein affects the reaction [Neomycin results in increased phosphorylation of JUN protein]
|
CTD |
PMID:10627579 PMID:39667535 |
|
NCBI chr 5:115,009,900...115,012,993
Ensembl chr 5:114,973,151...115,013,285
|
|
G
|
Klf2
|
KLF transcription factor 2
|
increases expression
|
ISO
|
Neomycin results in increased expression of KLF2 mRNA
|
CTD |
PMID:30626089 |
|
NCBI chr16:17,555,136...17,557,768
Ensembl chr16:17,555,136...17,557,768
|
|
G
|
Kng2
|
kininogen 2
|
multiple interactions
|
EXP
|
[Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in increased expression of MAP1 protein
|
CTD |
PMID:30545405 |
|
NCBI chr11:91,418,470...91,440,841
Ensembl chr11:91,414,207...91,441,259
|
|
G
|
Krt16
|
keratin 16
|
multiple interactions
|
EXP
|
[Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in increased expression of KRT16 protein
|
CTD |
PMID:30545405 |
|
NCBI chr10:85,669,276...85,672,211
Ensembl chr10:85,669,276...85,672,211
|
|
G
|
Ldlr
|
low density lipoprotein receptor
|
multiple interactions
|
ISO
|
[Sodium Selenite results in increased abundance of Selenium] inhibits the reaction [[Vancomycin co-treated with Neomycin co-treated with Ampicillin co-treated with Metronidazole co-treated with Amphotericin B] results in increased expression of LDLR mRNA]; [Vancomycin co-treated with Neomycin co-treated with Ampicillin co-treated with Metronidazole co-treated with Amphotericin B] results in increased expression of LDLR mRNA
|
CTD |
PMID:36464106 |
|
NCBI chr 8:28,546,191...28,569,075
Ensembl chr 8:28,546,146...28,570,675
|
|
G
|
Lep
|
leptin
|
multiple interactions
|
ISO
|
[Vancomycin co-treated with Neomycin co-treated with Metronidazole co-treated with elemicin] results in increased expression of LEP mRNA
|
CTD |
PMID:34979169 |
|
NCBI chr 4:58,626,529...58,640,663
Ensembl chr 4:58,626,523...58,640,661
|
|
G
|
Lpin1
|
lipin 1
|
multiple interactions
|
ISO
|
[Sodium Selenite results in increased abundance of Selenium] inhibits the reaction [[Vancomycin co-treated with Neomycin co-treated with Ampicillin co-treated with Metronidazole co-treated with Amphotericin B] results in increased expression of LPIN1 mRNA]; [Vancomycin co-treated with Neomycin co-treated with Ampicillin co-treated with Metronidazole co-treated with Amphotericin B] results in increased expression of LPIN1 mRNA
|
CTD |
PMID:36464106 |
|
NCBI chr 6:45,039,110...45,145,845
Ensembl chr 6:45,041,522...45,145,991
|
|
G
|
Lyz2
|
lysozyme 2
|
multiple interactions
|
EXP
|
[Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in increased expression of LYZ2 protein
|
CTD |
PMID:30545405 |
|
NCBI chr 7:54,792,715...54,798,060
Ensembl chr 7:54,792,716...54,798,011
|
|
G
|
Mapk1
|
mitogen activated protein kinase 1
|
multiple interactions increases expression
|
ISO
|
2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [Neomycin results in increased phosphorylation of and results in increased activity of MAPK1 protein]; CASR protein promotes the reaction [Neomycin results in increased phosphorylation of and results in increased activity of MAPK1 protein]; Neomycin results in increased phosphorylation of and results in increased activity of MAPK1 protein Neomycin results in increased expression of MAPK1 protein modified form peoniflorin inhibits the reaction [Neomycin results in increased expression of MAPK1 protein modified form]
|
CTD |
PMID:17537980 PMID:29292089 |
|
NCBI chr11:97,462,025...97,529,193
Ensembl chr11:97,462,025...97,527,825
|
|
G
|
Mapk3
|
mitogen activated protein kinase 3
|
multiple interactions increases expression
|
ISO EXP
|
2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [Neomycin results in increased phosphorylation of and results in increased activity of MAPK3 protein]; CASR protein promotes the reaction [Neomycin results in increased phosphorylation of and results in increased activity of MAPK3 protein]; Neomycin results in increased phosphorylation of and results in increased activity of MAPK3 protein peoniflorin inhibits the reaction [Neomycin results in increased expression of MAPK3 protein modified form] [Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in increased expression of MAPK3 protein
|
CTD |
PMID:17537980 PMID:29292089 PMID:30545405 |
|
NCBI chr 1:190,797,189...190,803,411
Ensembl chr 1:190,797,185...190,803,411
|
|
G
|
Mlxip
|
MLX interacting protein
|
multiple interactions
|
ISO
|
[Vancomycin co-treated with Neomycin co-treated with Metronidazole] inhibits the reaction [elemicin results in increased expression of MLXIP mRNA]
|
CTD |
PMID:34979169 |
|
NCBI chr12:38,789,404...38,853,059
Ensembl chr12:38,789,404...38,853,059
|
|
G
|
Mthfd2
|
methylenetetrahydrofolate dehydrogenase (NADP+ dependent) 2, methenyltetrahydrofolate cyclohydrolase
|
multiple interactions decreases expression
|
ISO
|
Plant Oils inhibits the reaction [Neomycin results in decreased expression of MTHFD2 mRNA]
|
CTD |
PMID:30626089 |
|
NCBI chr 4:117,368,833...117,380,350
Ensembl chr 4:117,368,835...117,380,350
|
|
G
|
Myd88
|
MYD88, innate immune signal transduction adaptor
|
multiple interactions
|
ISO
|
[Neomycin co-treated with Metronidazole co-treated with Ampicillin co-treated with Vancomycin] inhibits the reaction [Methamphetamine results in increased expression of MYD88 mRNA]; [Neomycin co-treated with Metronidazole co-treated with Ampicillin co-treated with Vancomycin] inhibits the reaction [Methamphetamine results in increased expression of MYD88 protein]
|
CTD |
PMID:35390362 |
|
NCBI chr 8:127,952,161...127,956,230
Ensembl chr 8:127,952,161...127,956,230
|
|
G
|
Myh14
|
myosin heavy chain 14
|
multiple interactions
|
EXP
|
[Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in increased expression of MYH14 protein
|
CTD |
PMID:30545405 |
|
NCBI chr 1:104,232,778...104,295,369
Ensembl chr 1:104,232,778...104,323,404
|
|
G
|
Ndufa13
|
NADH:ubiquinone oxidoreductase subunit A13
|
multiple interactions
|
EXP
|
[Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in increased expression of NDUFA13 protein
|
CTD |
PMID:30545405 |
|
NCBI chr16:19,560,526...19,567,500
Ensembl chr 7:32,257,006...32,257,492
|
|
G
|
Ndufab1
|
NADH:ubiquinone oxidoreductase subunit AB1
|
multiple interactions
|
EXP
|
[Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in increased expression of NDUFAB1 protein
|
CTD |
PMID:30545405 |
|
NCBI chr 1:186,075,933...186,091,843
Ensembl chr 1:186,057,113...186,089,373
|
|
G
|
Nog
|
noggin
|
increases expression
|
ISO
|
Neomycin results in increased expression of NOG mRNA
|
CTD |
PMID:30626089 |
|
NCBI chr10:74,625,874...74,627,501
Ensembl chr10:74,625,875...74,628,103
|
|
G
|
Nol3
|
nucleolar protein 3
|
decreases expression multiple interactions
|
ISO
|
Neomycin results in decreased expression of NOL3 protein FTI 277 promotes the reaction [Neomycin results in decreased expression of NOL3 protein]; NOL3 protein affects the reaction [Neomycin results in increased cleavage of CASP3 protein]; NOL3 protein affects the reaction [Neomycin results in increased phosphorylation of CREB1 protein]; NOL3 protein affects the reaction [Neomycin results in increased phosphorylation of JUN protein]
|
CTD |
PMID:39667535 |
|
NCBI chr19:50,066,493...50,068,175
Ensembl chr19:50,063,986...50,068,722
|
|
G
|
Nos2
|
nitric oxide synthase 2
|
multiple interactions
|
ISO
|
[Vancomycin co-treated with Neomycin co-treated with Cilastatin, Imipenem Drug Combination] inhibits the reaction [Doxorubicin results in increased expression of NOS2 mRNA]; [Vancomycin co-treated with Neomycin co-treated with Cilastatin, Imipenem Drug Combination] inhibits the reaction [Nanotubes, Carbon promotes the reaction [Doxorubicin results in increased expression of NOS2 mRNA]]
|
CTD |
PMID:32068018 |
|
NCBI chr10:64,313,335...64,349,221
Ensembl chr10:64,313,335...64,401,880
|
|
G
|
Npc1l1
|
NPC1 like intracellular cholesterol transporter 1
|
multiple interactions
|
ISO
|
[Cephalothin co-treated with Neomycin] results in increased expression of NPC1L1 mRNA
|
CTD |
PMID:24657338 |
|
NCBI chr14:85,285,387...85,305,050
Ensembl chr14:85,285,390...85,305,050
|
|
G
|
Npc2
|
NPC intracellular cholesterol transporter 2
|
multiple interactions
|
EXP
|
[Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in decreased expression of NPC2 protein
|
CTD |
PMID:30545405 |
|
NCBI chr 6:110,128,325...110,149,245
Ensembl chr 6:110,128,325...110,150,004
|
|
G
|
Nr0b2
|
nuclear receptor subfamily 0, group B, member 2
|
multiple interactions
|
ISO
|
[Vancomycin co-treated with Metronidazole co-treated with Ampicillin co-treated with Neomycin] inhibits the reaction [bisphenol A results in decreased expression of NR0B2 protein]
|
CTD |
PMID:37211107 |
|
NCBI chr 5:151,063,160...151,066,475
Ensembl chr 5:151,063,160...151,066,475
|
|
G
|
Nr1h4
|
nuclear receptor subfamily 1, group H, member 4
|
multiple interactions
|
ISO
|
[Vancomycin co-treated with Metronidazole co-treated with Ampicillin co-treated with Neomycin] inhibits the reaction [bisphenol A results in decreased expression of NR1H4 protein]
|
CTD |
PMID:37211107 |
|
NCBI chr 7:25,733,471...25,829,440
Ensembl chr 7:25,733,471...25,829,389
|
|
G
|
Nr5a2
|
nuclear receptor subfamily 5, group A, member 2
|
multiple interactions
|
ISO
|
[Cephalothin co-treated with Neomycin] results in increased expression of NR5A2 mRNA
|
CTD |
PMID:24657338 |
|
NCBI chr13:50,865,253...50,985,107
Ensembl chr13:50,867,920...50,984,938
|
|
G
|
Ocln
|
occludin
|
multiple interactions
|
ISO
|
[Neomycin co-treated with Metronidazole co-treated with Ampicillin co-treated with Vancomycin] inhibits the reaction [Methamphetamine results in decreased expression of OCLN mRNA]; [Neomycin co-treated with Metronidazole co-treated with Ampicillin co-treated with Vancomycin] inhibits the reaction [Methamphetamine results in decreased expression of OCLN protein]
|
CTD |
PMID:35390362 |
|
NCBI chr 2:33,391,303...33,442,207
Ensembl chr 2:33,391,303...33,430,411
|
|
G
|
Pfn1
|
profilin 1
|
multiple interactions
|
EXP
|
[Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in increased expression of PFN1 protein
|
CTD |
PMID:30545405 |
|
NCBI chr10:55,863,882...55,866,587
Ensembl chr10:55,863,881...55,868,611
|
|
G
|
Pgam1
|
phosphoglycerate mutase 1
|
multiple interactions
|
EXP
|
[Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in increased expression of PGAM1 protein
|
CTD |
PMID:30545405 |
|
NCBI chr 1:250,673,152...250,680,762
Ensembl chr 1:250,673,049...250,690,203
|
|
G
|
Pmm2
|
phosphomannomutase 2
|
multiple interactions
|
EXP
|
[Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in increased expression of PMM2 protein
|
CTD |
PMID:30545405 |
|
NCBI chr10:7,468,371...7,489,574
Ensembl chr10:7,468,372...7,489,554
|
|
G
|
Ppp1ca
|
protein phosphatase 1 catalytic subunit alpha
|
multiple interactions
|
EXP
|
[Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in increased expression of PPP1CA protein
|
CTD |
PMID:30545405 |
|
NCBI chr 1:210,914,576...210,918,193
Ensembl chr 1:210,914,567...210,918,193
|
|
G
|
Ppp1cb
|
protein phosphatase 1 catalytic subunit beta
|
multiple interactions
|
EXP
|
[Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in increased expression of PPP1CB protein
|
CTD |
PMID:30545405 |
|
NCBI chr 6:29,681,099...29,712,835
Ensembl chr 6:29,681,100...29,712,924
|
|
G
|
Ppp1cc
|
protein phosphatase 1 catalytic subunit gamma
|
multiple interactions
|
EXP
|
[Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in increased expression of PPP1CC protein
|
CTD |
PMID:30545405 |
|
NCBI chr12:40,043,822...40,061,301
Ensembl chr12:40,043,822...40,061,341
|
|
G
|
Psat1
|
phosphoserine aminotransferase 1
|
multiple interactions decreases expression
|
ISO
|
Plant Oils inhibits the reaction [Neomycin results in decreased expression of PSAT1 mRNA]
|
CTD |
PMID:30626089 |
|
NCBI chr 1:222,623,553...222,646,187
Ensembl chr 1:222,623,556...222,655,693
|
|
G
|
Psma3
|
proteasome 20S subunit alpha 3
|
multiple interactions
|
EXP
|
[Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in decreased expression of PSMA3 protein
|
CTD |
PMID:30545405 |
|
NCBI chr 6:95,219,714...95,239,745
Ensembl chr 6:95,219,629...95,241,032
|
|
G
|
Psph
|
phosphoserine phosphatase
|
decreases expression multiple interactions
|
ISO
|
Neomycin results in decreased expression of PSPH mRNA Plant Oils inhibits the reaction [Neomycin results in decreased expression of PSPH mRNA]
|
CTD |
PMID:30626089 |
|
NCBI chr12:32,527,091...32,541,182
Ensembl chr12:32,519,269...32,541,180
|
|
G
|
Ralb
|
RAS like proto-oncogene B
|
multiple interactions
|
EXP
|
[Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in decreased expression of RALB protein
|
CTD |
PMID:30545405 |
|
NCBI chr13:33,140,834...33,176,997
Ensembl chr13:33,140,835...33,176,998
|
|
G
|
Ran
|
RAN, member RAS oncogene family
|
multiple interactions
|
EXP
|
[Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in increased expression of RAN protein
|
CTD |
PMID:30545405 |
|
NCBI chr12:33,311,155...33,314,339
Ensembl chr12:33,311,158...33,314,317
|
|
G
|
Rela
|
RELA proto-oncogene, NF-kB subunit
|
multiple interactions
|
ISO
|
[Neomycin co-treated with Metronidazole co-treated with Ampicillin co-treated with Vancomycin] inhibits the reaction [Methamphetamine results in increased expression of RELA mRNA]; [Neomycin co-treated with Metronidazole co-treated with Ampicillin co-treated with Vancomycin] inhibits the reaction [Methamphetamine results in increased expression of RELA protein]
|
CTD |
PMID:35390362 |
|
NCBI chr 1:212,354,336...212,364,815
Ensembl chr 1:212,333,035...212,364,817
|
|
G
|
Rida
|
reactive intermediate imine deaminase A homolog
|
multiple interactions
|
EXP
|
[Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in decreased expression of RIDA protein
|
CTD |
PMID:30545405 |
|
NCBI chr 7:67,576,586...67,590,493
Ensembl chr 7:67,576,586...67,590,692
|
|
G
|
Rpl30
|
ribosomal protein L30
|
multiple interactions
|
EXP
|
[Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in increased expression of RPL30 protein
|
CTD |
PMID:30545405 |
|
NCBI chr 7:67,533,420...67,536,555
Ensembl chr 7:67,465,332...67,536,555
|
|
G
|
Rpn2
|
ribophorin II
|
multiple interactions
|
EXP
|
[Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in increased expression of RPN2 protein
|
CTD |
PMID:30545405 |
|
NCBI chr 3:166,361,955...166,409,272
Ensembl chr 3:166,362,049...166,409,922
|
|
G
|
Rps23
|
ribosomal protein S23
|
multiple interactions
|
EXP
|
[Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in increased expression of RPS23 protein
|
CTD |
PMID:30545405 |
|
NCBI chr 2:23,814,517...23,816,087
Ensembl chr 2:23,814,497...23,816,088
|
|
G
|
Rps27l
|
ribosomal protein S27-like
|
multiple interactions
|
EXP
|
[Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in increased expression of RPS27L protein
|
CTD |
PMID:30545405 |
|
NCBI chr 8:76,443,658...76,448,593
Ensembl chr12:33,713,661...33,714,130 Ensembl chr 8:33,713,661...33,714,130
|
|
G
|
Rps6kb1
|
ribosomal protein S6 kinase B1
|
affects phosphorylation
|
ISO
|
Neomycin affects the phosphorylation of RPS6KB1 protein
|
CTD |
PMID:16537399 |
|
NCBI chr10:71,817,794...71,865,211
Ensembl chr10:71,815,614...71,865,238
|
|
G
|
RT1-DMb
|
RT1 class II, locus DMb
|
multiple interactions
|
EXP
|
[Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in decreased expression of RT1-DMB protein
|
CTD |
PMID:30545405 |
|
NCBI chr20:4,695,009...4,702,560
Ensembl chr20:4,695,010...4,702,246
|
|
G
|
S100a10
|
S100 calcium binding protein A10
|
multiple interactions
|
EXP
|
[Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in increased expression of S100A10 protein
|
CTD |
PMID:30545405 |
|
NCBI chr 2:181,904,454...181,913,101
Ensembl chr 2:181,904,261...181,913,103
|
|
G
|
S100a11
|
S100 calcium binding protein A11
|
multiple interactions
|
EXP
|
[Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in increased expression of S100A11 protein
|
CTD |
PMID:30545405 |
|
NCBI chr 2:181,875,132...181,880,542
Ensembl chr 2:181,875,130...181,880,541
|
|
G
|
Scarb2
|
scavenger receptor class B, member 2
|
multiple interactions
|
EXP
|
[Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in decreased expression of SCARB2 protein
|
CTD |
PMID:30545405 |
|
NCBI chr14:15,842,583...15,894,123
Ensembl chr14:15,842,515...15,896,671
|
|
G
|
Scd
|
stearoyl-CoA desaturase
|
multiple interactions
|
ISO
|
[Vancomycin co-treated with Metronidazole co-treated with Ampicillin co-treated with Neomycin] inhibits the reaction [bisphenol A results in increased expression of SCD1 protein]
|
CTD |
PMID:37211107 |
|
NCBI chr 1:253,218,968...253,232,101
Ensembl chr 1:253,218,970...253,231,785
|
|
G
|
Serpinb6a
|
serpin family B member 6A
|
multiple interactions
|
EXP
|
[Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in increased expression of SERPINB6 protein
|
CTD |
PMID:30545405 |
|
NCBI chr17:31,076,811...31,195,035
Ensembl chr17:31,158,622...31,196,545
|
|
G
|
Shmt2
|
serine hydroxymethyltransferase 2
|
decreases expression multiple interactions
|
ISO EXP
|
Neomycin results in decreased expression of SHMT2 mRNA [Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in increased expression of SHMT2 protein
|
CTD |
PMID:30545405 PMID:30626089 |
|
NCBI chr 7:65,244,247...65,249,580
Ensembl chr 7:65,244,247...65,249,567
|
|
G
|
Slc10a1
|
solute carrier family 10 member 1
|
multiple interactions
|
ISO
|
[Cephalothin co-treated with Neomycin] results in increased expression of SLC10A1 mRNA
|
CTD |
PMID:24657338 |
|
NCBI chr 6:106,344,319...106,357,944
Ensembl chr 6:106,344,319...106,357,944
|
|
G
|
Slc22a7
|
solute carrier family 22 member 7
|
multiple interactions
|
ISO
|
[Vancomycin co-treated with Neomycin co-treated with Ampicillin co-treated with Metronidazole co-treated with Amphotericin B] results in increased expression of SLC22A7 mRNA
|
CTD |
PMID:36464106 |
|
NCBI chr 9:22,044,672...22,052,051
Ensembl chr 9:22,045,435...22,051,681
|
|
G
|
Slc3a1
|
solute carrier family 3 member 1
|
multiple interactions
|
EXP
|
[Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in increased expression of SLC3A1 protein
|
CTD |
PMID:30545405 |
|
NCBI chr 6:15,361,037...15,396,695
Ensembl chr 6:15,361,046...15,394,775
|
|
G
|
Slc51b
|
SLC51 subunit beta
|
multiple interactions
|
ISO
|
[Cephalothin co-treated with Neomycin] results in decreased expression of SLC51B mRNA
|
CTD |
PMID:24657338 |
|
NCBI chr 8:74,827,047...74,835,109
Ensembl chr 8:74,827,047...74,835,109
|
|
G
|
Slco1b2
|
solute carrier organic anion transporter family member 1B2
|
multiple interactions
|
ISO
|
[Cephalothin co-treated with Neomycin] results in increased expression of SLCO1B2 mRNA
|
CTD |
PMID:24657338 |
|
NCBI chr 4:176,282,577...176,355,557
Ensembl chr 4:176,282,584...176,351,083
|
|
G
|
Smad6
|
SMAD family member 6
|
increases expression
|
ISO
|
Neomycin results in increased expression of SMAD6 mRNA
|
CTD |
PMID:30626089 |
|
NCBI chr 8:73,345,457...73,414,985
Ensembl chr 8:73,345,460...73,414,149
|
|
G
|
Smad9
|
SMAD family member 9
|
increases expression
|
ISO
|
Neomycin results in increased expression of SMAD9 mRNA
|
CTD |
PMID:30626089 |
|
NCBI chr 2:141,106,668...141,156,477
Ensembl chr 2:141,106,668...141,156,477
|
|
G
|
Smpd2
|
sphingomyelin phosphodiesterase 2
|
multiple interactions
|
EXP
|
[Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in increased expression of SMPD2 protein
|
CTD |
PMID:30545405 |
|
NCBI chr20:46,568,627...46,571,741
Ensembl chr20:46,568,629...46,571,741
|
|
G
|
Sqle
|
squalene epoxidase
|
multiple interactions
|
ISO
|
[Vancomycin co-treated with Neomycin co-treated with Ampicillin co-treated with Metronidazole co-treated with Amphotericin B] results in increased expression of SQLE mRNA
|
CTD |
PMID:36464106 |
|
NCBI chr 7:92,758,175...92,773,049
Ensembl chr 7:92,757,409...92,773,050
|
|
G
|
Sqstm1
|
sequestosome 1
|
multiple interactions
|
ISO
|
[Vancomycin co-treated with Neomycin co-treated with Metronidazole] promotes the reaction [Zinc Oxide analog results in increased expression of SQSTM1 protein]
|
CTD |
PMID:36535435 |
|
NCBI chr10:35,026,598...35,037,750
Ensembl chr10:35,026,598...35,037,750
|
|
G
|
Srebf1
|
sterol regulatory element binding transcription factor 1
|
multiple interactions
|
ISO
|
[Sodium Selenite results in increased abundance of Selenium] inhibits the reaction [[Vancomycin co-treated with Neomycin co-treated with Ampicillin co-treated with Metronidazole co-treated with Amphotericin B] results in increased expression of SREBF1 mRNA]; [Vancomycin co-treated with Metronidazole co-treated with Ampicillin co-treated with Neomycin] inhibits the reaction [bisphenol A results in increased expression of SREBF1 protein]; [Vancomycin co-treated with Neomycin co-treated with Ampicillin co-treated with Metronidazole co-treated with Amphotericin B] results in increased expression of SREBF1 mRNA
|
CTD |
PMID:36464106 PMID:37211107 |
|
NCBI chr10:45,507,152...45,529,164
Ensembl chr10:45,507,152...45,529,164
|
|
G
|
Srebf2
|
sterol regulatory element binding transcription factor 2
|
multiple interactions
|
ISO
|
[Vancomycin co-treated with Neomycin co-treated with Ampicillin co-treated with Metronidazole co-treated with Amphotericin B] results in increased expression of SREBF2 mRNA
|
CTD |
PMID:36464106 |
|
NCBI chr 7:115,542,774...115,600,945
Ensembl chr 7:115,543,290...115,600,943
|
|
G
|
Sst
|
somatostatin
|
multiple interactions
|
ISO
|
[Vancomycin co-treated with Neomycin co-treated with Metronidazole] promotes the reaction [Zinc Oxide results in increased expression of SST mRNA]; [Vancomycin co-treated with Neomycin co-treated with Metronidazole] results in increased expression of SST mRNA
|
CTD |
PMID:36535435 |
|
NCBI chr11:90,461,546...90,462,823
Ensembl chr11:90,461,546...90,462,823
|
|
G
|
Sstr2
|
somatostatin receptor 2
|
multiple interactions
|
ISO
|
[Vancomycin co-treated with Neomycin co-treated with Metronidazole] promotes the reaction [Zinc Oxide results in increased expression of SSTR2 mRNA]
|
CTD |
PMID:36535435 |
|
NCBI chr10:99,163,353...99,170,519
Ensembl chr10:99,162,740...99,183,863
|
|
G
|
Stk26
|
serine/threonine kinase 26
|
multiple interactions
|
EXP
|
[Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in decreased expression of PDXK protein
|
CTD |
PMID:30545405 |
|
NCBI chr X:135,195,176...135,259,994
Ensembl chr X:135,195,204...135,259,993
|
|
G
|
Tars1
|
threonyl-tRNA synthetase 1
|
multiple interactions
|
EXP
|
[Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in increased expression of TARS1 protein
|
CTD |
PMID:30545405 |
|
NCBI chr 2:62,095,978...62,114,802
Ensembl chr 2:62,087,763...62,114,802
|
|
G
|
Tgfb2
|
transforming growth factor, beta 2
|
increases expression multiple interactions
|
ISO
|
Neomycin results in increased expression of TGFB2 mRNA Plant Oils inhibits the reaction [Neomycin results in increased expression of TGFB2 mRNA]
|
CTD |
PMID:30626089 |
|
NCBI chr13:100,691,540...100,793,227
Ensembl chr13:100,692,953...100,792,856
|
|
G
|
Tjp1
|
tight junction protein 1
|
multiple interactions
|
ISO
|
[Neomycin co-treated with Metronidazole co-treated with Ampicillin co-treated with Vancomycin] inhibits the reaction [Methamphetamine results in decreased expression of TJP1 mRNA]; [Neomycin co-treated with Metronidazole co-treated with Ampicillin co-treated with Vancomycin] inhibits the reaction [Methamphetamine results in decreased expression of TJP1 protein]
|
CTD |
PMID:35390362 |
|
NCBI chr 1:128,260,330...128,505,018
Ensembl chr 1:128,260,330...128,505,158
|
|
G
|
Tlr4
|
toll-like receptor 4
|
multiple interactions
|
ISO
|
[Neomycin co-treated with Metronidazole co-treated with Ampicillin co-treated with Vancomycin] inhibits the reaction [Methamphetamine results in increased expression of TLR4 mRNA]; [Neomycin co-treated with Metronidazole co-treated with Ampicillin co-treated with Vancomycin] inhibits the reaction [Methamphetamine results in increased expression of TLR4 protein]; TLR4 gene mutant form results in decreased susceptibility to [Neomycin co-treated with Metronidazole co-treated with Ampicillin co-treated with Vancomycin]
|
CTD |
PMID:35390362 |
|
NCBI chr 5:85,161,247...85,174,882
Ensembl chr 5:85,161,192...85,175,007
|
|
G
|
Tm9sf2
|
transmembrane 9 superfamily member 2
|
multiple interactions
|
EXP
|
[Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in increased expression of TM9SF2 protein
|
CTD |
PMID:30545405 |
|
NCBI chr15:105,606,082...105,660,715
Ensembl chr15:105,606,118...105,660,714
|
|
G
|
Tmed10
|
transmembrane p24 trafficking protein 10
|
multiple interactions
|
EXP
|
[Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in increased expression of TMED10 protein
|
CTD |
PMID:30545405 |
|
NCBI chr 6:110,722,887...110,757,743
Ensembl chr 6:110,722,889...110,757,777
|
|
G
|
Tnf
|
tumor necrosis factor
|
multiple interactions
|
ISO
|
[Ampicillin co-treated with Vancomycin co-treated with Neomycin co-treated with Metronidazole] inhibits the reaction [Dextran Sulfate results in increased expression of TNF protein]; [Ampicillin co-treated with Vancomycin co-treated with Neomycin co-treated with Metronidazole] results in decreased expression of TNF protein; [Neomycin co-treated with Metronidazole co-treated with Ampicillin co-treated with Vancomycin] inhibits the reaction [Methamphetamine results in increased expression of and results in increased secretion of TNF protein]; [Neomycin co-treated with Metronidazole co-treated with Ampicillin co-treated with Vancomycin] inhibits the reaction [Methamphetamine results in increased expression of TNF mRNA]; [Vancomycin co-treated with Neomycin co-treated with Cilastatin, Imipenem Drug Combination] inhibits the reaction [Doxorubicin results in increased expression of TNF protein]; [Vancomycin co-treated with Neomycin co-treated with Cilastatin, Imipenem Drug Combination] inhibits the reaction [Nanotubes, Carbon promotes the reaction [Doxorubicin results in increased expression of TNF protein]]; Dextran Sulfate inhibits the reaction [[Ampicillin co-treated with Vancomycin co-treated with Neomycin co-treated with Metronidazole] results in decreased expression of TNF protein]
|
CTD |
PMID:31442584 PMID:32068018 PMID:35390362 |
|
NCBI chr20:3,626,685...3,629,303
Ensembl chr20:3,626,532...3,629,303
|
|
G
|
Traf6
|
TNF receptor associated factor 6
|
multiple interactions
|
ISO
|
[Neomycin co-treated with Metronidazole co-treated with Ampicillin co-treated with Vancomycin] inhibits the reaction [Methamphetamine results in increased expression of TRAF6 mRNA]; [Neomycin co-treated with Metronidazole co-treated with Ampicillin co-treated with Vancomycin] inhibits the reaction [Methamphetamine results in increased expression of TRAF6 protein]
|
CTD |
PMID:35390362 |
|
NCBI chr 3:108,418,537...108,443,330
Ensembl chr 3:108,418,513...108,443,328
|
|
G
|
Tubal3
|
tubulin, alpha-like 3
|
multiple interactions
|
EXP
|
[Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in increased expression of TUBAL3 protein
|
CTD |
PMID:30545405 |
|
NCBI chr17:71,233,194...71,245,297
Ensembl chr17:71,232,851...71,245,337
|
|
G
|
Twf1
|
twinfilin actin-binding protein 1
|
multiple interactions
|
EXP
|
[Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in increased expression of TWF1 protein
|
CTD |
PMID:30545405 |
|
NCBI chr 7:127,595,210...127,607,821
Ensembl chr 7:127,595,210...127,607,105
|
|
G
|
Txn1
|
thioredoxin 1
|
multiple interactions
|
ISO
|
[Vancomycin co-treated with Neomycin co-treated with Metronidazole] promotes the reaction [Zinc Oxide analog results in increased expression of TXN1 protein]
|
CTD |
PMID:36535435 |
|
NCBI chr 5:77,507,455...77,519,685
Ensembl chr 5:77,507,321...77,520,307
|
|
G
|
Txndc5
|
thioredoxin domain containing 5
|
multiple interactions
|
EXP
|
[Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in increased expression of TXNDC5 protein
|
CTD |
PMID:30545405 |
|
NCBI chr17:26,495,467...26,523,608
Ensembl chr17:26,490,047...26,523,597
|
|
G
|
Uqcrc1
|
ubiquinol-cytochrome c reductase core protein 1
|
multiple interactions
|
EXP
|
[Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in increased expression of UQCRC1 protein
|
CTD |
PMID:30545405 |
|
NCBI chr 8:118,468,223...118,479,968
Ensembl chr 8:118,468,200...118,479,964
|
|
G
|
Uqcrfs1
|
ubiquinol-cytochrome c reductase, Rieske iron-sulfur polypeptide 1
|
multiple interactions
|
EXP
|
[Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in increased expression of UQCRFS1 protein
|
CTD |
PMID:30545405 |
|
NCBI chr17:34,173,787...34,190,952
Ensembl chr17:34,173,833...34,190,950
|
|
G
|
Uqcrh
|
ubiquinol-cytochrome c reductase hinge protein
|
multiple interactions
|
EXP
|
[Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in increased expression of UQCRH protein
|
CTD |
PMID:30545405 |
|
NCBI chr 5:134,782,687...134,790,882
Ensembl chr 5:134,782,255...134,790,926
|
|
G
|
Vdr
|
vitamin D receptor
|
multiple interactions
|
ISO
|
[Cephalothin co-treated with Neomycin] results in increased expression of VDR mRNA
|
CTD |
PMID:24657338 |
|
NCBI chr 7:130,864,764...130,916,757
Ensembl chr 7:130,866,745...130,916,757
|
|